Texas Instruments 3Q26: The 300mm payoff is here; Maintain BUY

Texas Instruments’ strong 3Q26 earnings confirm its 300mm manufacturing advantage, supporting market-share gains and sustained earnings growth. We maintain BUY and raise our target price to USD391.

iFAST Research Team
iFAST Research Team30 Oct 2026 22 Views
Texas Instruments 3Q26: The 300mm payoff is here; Maintain BUY

Key Points

  • TI's investments in manufacturing capacity and inventory during the downturn position it to capture recovering analog demand and potentially gain market share.
  • Rising semiconductor content in AI infrastructure and industrial applications supports longer-term growth, while capex discipline and Silicon Labs integration remain key execution tests.
  • We raise our end-2028 target price to USD391 from USD346, implying 27% upside, supported by stronger earnings forecasts and TI's structural manufacturing advantages.
  • TI's 3Q26 revenue rose 28% YoY to USD6.06bn, while EPS jumped 77% and gross margin expanded to 64.2%, reflecting more cost-efficient 300mm factories is beginning to pay off.

Texas Instruments (TI) delivered another strong quarter, and Q3 confirmed that its 300mm manufacturing strategy is delivering operating leverage sooner than we expected. We maintain our BUY call and raise our target price to USD391 from USD346, representing 27% upside from USD308.91. We remain positive because TI's ability to supply customers during industry constraints creates potential market-share opportunities, while higher semiconductor content in AI infrastructure and industrial equipment supports growth beyond the current analog recovery. Customer design wins, sustained gross-margin conversion, FY2027 capex and Silicon Labs integration will determine whether the stronger earnings outlook translates into sustainable shareholder returns.

Figure 1: Texas Instruments’ share price


Texas Instruments’ 3Q26 earnings summary

TI reported Q3 revenue of USD6.06bn, up 28% YoY and around 2.5% above consensus. Gross margin rose 680bps YoY to 64.2%, 240bps above consensus. Operating profit rose 73% to USD2.87bn and EPS rose 77% to USD2.62, above the top end of guidance. Profit growth far outpaced sales, as we expected from higher utilisation of TI's 300mm factories.

Table 1: Texas Instruments’ 3Q26 earnings summary

Metric

Q3 26

Q2 26

Q3 25

QoQ

YoY

Consensus/Guide

Beat/Miss (Variance)

Revenue (USD bn)

6.06

5.46

4.74

10.80%

27.70%

Consensus USD 5.90–5.92bn; Guide USD 5.65–6.15bn

Beat (+2.5%)

Gross margin

64.20%

61.40%

57.40%

+280bps

+680bps

Consensus 61.8%

Beat (+240bps)

Operating expenses (USD bn)

1.01

1.04

1.06

-2.80%

-4.40%

Consensus USD 1.02bn

In line (-0.7%)

Operating income (USD bn)

2.87

2.31

1.66

24.40%

72.80%

Consensus USD 2.62bn

Beat (+9.7%)

Operating margin

47.50%

42.30%

35.10%

+520bps

+1,240bps

Consensus 44.5%

Beat (+300bps)

Net income (USD bn)

2.43

1.98

1.36

22.50%

77.80%

Consensus USD 2.23bn

Beat (+8.7%)

Diluted EPS

USD 2.62

USD 2.14

USD 1.48

22.40%

77.00%

Consensus USD 2.41–2.43; Guide USD 2.23–2.57

Beat (+8.3%)

Free cash flow (CFO – capex, USD bn)

2.96

2.19

0.99

35.00%

198%

Consensus USD 2.26bn

Beat (+31.0%)

Source: Bloomberg Finance L.P., iFAST compilations. Data as of 27 October 2026.

Table 2: Revenue segmentation

Business unit (USD mn)

Q3 26

% of rev

QoQ

YoY

Analog

4,911

81%

12.5%

31.7%

Embedded Processing

858

14%

8.9%

21.0%

Other

286

5%

-7.7%

-5.9%

Total

6,055

100%

10.8%

27.7%

Source: Bloomberg Finance L.P., iFAST compilations. Data as of 27 October 2026.

 

The recovery is now broad-based. Industrial revenue grew more than 40% YoY to above its 2022 peak, automotive grew in the mid-teens, and data-centre revenue rose roughly 95% to about 13% of sales. With price increases described as relatively modest, TI is selling more chips rather than simply charging more.

Table 3: Revenue by end market

End market

YoY

QoQ

Management commentary

Industrial

>40%

~10%

First new peak since Q3 22; aerospace and defence, energy infrastructure, test and measurement, robotics

Automotive

Mid-teens

~10%

Low customer inventories; China and the US lead; hybrid and EV powertrain grew about twice the segment rate

Data centre

~95%

~20%

About 13% of revenue; about 10,000 part numbers sold in; no slowdown seen

Personal electronics

Flat

Upper single digits

–

Source: Bloomberg Finance L.P., iFAST compilations. Data as of 27 October 2026.


Q4 guidance indicates demand has carried into year-end

Management guided Q4 revenue to USD5.80–6.30bn. The USD6.05bn midpoint is broadly flat on Q3 and better than the usual seasonal decline, suggesting industrial, automotive and data-centre orders remain supportive. The EPS midpoint of USD2.62 is also flat sequentially. The question now is whether underlying demand can sustain growth into 2027, with potential distributor restocking providing additional upside.

TI kept FY2026 gross capex at USD2–3bn and will outline its FY2027 approach in February; its 10% and mid-teens growth scenarios illustrate equipment needs, not guidance. Annual pricing negotiations are underway, but we include little price contribution until realised prices are clearer.

Table 4: Texas Instruments’ guidance and FY27 outlook

Metric

Q4 26 guidance

Management outlook

Revenue

USD 5.80–6.30bn

Above seasonal (Q4 normally falls by a mid- to high-single-digit percentage); consensus USD 5.73–5.75bn, so the midpoint is +5.4% above

Diluted EPS

USD 2.45–2.79

Consensus USD 2.27–2.29, so the midpoint is +14.7% above

Gross margin

–

Q3 ~90% incremental fall-through; long-term model 75–85%

Operating expenses

Flat to slightly up QoQ

Acquisition charges and net other income similar to Q3

Tax rate

~13%

13–14% in FY27

Capex

FY26 USD 2–3bn, higher end if tools arrive on time

FY27 framework at the February call, set by the growth target (~10% vs mid-teens)

Pricing

H2 26 uptick, mainly Analog, “not very significant this year”

2027 annual negotiations underway with a pricing element; more detail at the January call

Dividend

Raised 7% to USD 1.52 a quarter (23rd consecutive increase)

Aim to return all free cash flow over time

Source: Bloomberg Finance L.P., iFAST compilations. Data as of 27 October 2026.

The share price was little changed after the earnings release (+1.3% after hours). After a 60% year-to-date rally, and with the shares trading at 28x forward P/E close to its historical average of 26.3×, suggesting the rally has priced in improving earnings expectations. Investors now want evidence that volume growth can last into 2027, and at what capex.


The next growth opportunity lies ahead

In our May article, “Texas Instruments FY26: 300mm strategy”, we argued that TI's 300mm factories would become a cost advantage as industrial demand recovered. Our August update, “Texas Instruments Q226: Slowly but surely”, set three tests: unit-led growth with stronger margins, FY2027 capex discipline, and Silicon Labs integration. Q3 passed the first, with capex and acquisition execution still needing confirmation.


The 300mm investment is becoming an earnings advantage

TI built capacity ahead of the recovery, so depreciation initially weighed on margins. As volumes rise, fixed costs are spread across more chips. Q3's 64.2% gross margin already exceeds the 62.8% full-year margin we forecast for FY2028 in August.

Margins depend on what TI produces, not only what it sells. TI can meet immediate customer demand from its existing inventory while progressively increasing factory output; inventory still edged up from about USD4.61bn in Q2 to USD4.67bn in Q3 despite stronger sales. Higher utilisation and improved cost absorption should therefore support earnings growth as demand strengthens. Depreciation from new tools, product mix and seasonality can still move margins, but Q3 suggests that even if our forecast is wrong, it's probably too conservative.


Inventory investments position TI to regain market share

TI's decision to invest through the analog downturn is positioning it to regain market share. TI's share of global analog revenue declined from around 20% in 2020–21 to approximately 15% in 2024, before recovering towards 17% in 2026, with UBS forecasting 19% by 2027. We believe this recovery reflects TI's manufacturing and inventory investments during a period when competitors were reducing spending. TI maintained annual capex of USD4.5–5.1bn throughout FY2023–25 to expand its 300mm manufacturing network, while ADI reduced annual spending from USD1.26bn to USD0.53bn.

TI's inventory strategy provides a second advantage. At end-3Q26, TI held USD1.69bn of finished goods, equivalent to approximately 72 days of quarterly production costs, compared with around 27 days for ADI and 35 days for NXP based on their latest filings. Combined with its available manufacturing capacity, this larger buffer allows TI to respond to recovering demand and commit future supply while competitors face longer lead times. Meanwhile, TI's total inventory days declined from 222 at end-2025 to 194 in Q3, while finished goods fell from USD1.97bn to USD1.69bn, indicating that stronger demand is helping absorb inventory accumulated.

Figure 2: TI's larger inventory buffer provides greater supply flexibility as analog demand recovers

Management confirmed that industrial and data-centre customers have approached TI to secure components while facing shortages elsewhere in their supply chains. While this does not necessarily represent market-share gains, TI's supply reliability could strengthen customer relationships and create opportunities for new design wins. Its 300mm manufacturing cost advantage also allows TI to remain price-competitive as industry supply normalises. We believe the longer-term opportunity lies in securing additional positions in customer designs, as analog components often remain in production for years. However, some supply-driven demand could normalise as competitors recover, making sustained above-market growth and new design wins critical to confirming whether TI can retain its market-share gains.


Higher semiconductor content extends growth beyond the cycle

Data centres were a pillar of our May thesis, and Q3's near-doubling of data-centre revenue supports it. Higher-power AI racks need more voltage conversion, control, sensing and protection alongside GPUs, and TI's analog portfolio and 800V power work position it to compete. The opportunity comes from more chips per rack, not just more data centres.

Mizuho expects AI data-centre power to rise from 3% of the global analog market in 2025 to 12% in 2028 and 26% by 2030, a runway beyond our original forecast horizon. Adoption may be delayed and competitors also supply high-voltage stages, so we watch for TI-specific design wins and higher-voltage rollout schedules.

Industrial applications offer growth beyond a cyclical rebound. Factory automation, robotics and grid upgrades need more sensors, controllers and power-management chips, so TI benefits from both higher equipment output and rising chip content per system, making growth less dependent on the industrial cycle.

Figure 3: Analog semiconductor market and AI data-centre power share


Cash conversion and Silicon Labs remain the final tests

The cash-flow recovery is underway. Over the latest 12 months, TI generated USD9.90bn of operating cash flow and spent USD2.58bn on capex, leaving about USD7.32bn of conventional FCF. February's FY2027 capex framework is a key catalyst for how much of the higher operating profit reaches FCF.

We remain positive on the logic of acquiring Silicon Labs. TI plans to move selected products from external foundries into its 300mm facilities, targeting more than USD450mn of annual synergies within three years of closing. Chinese regulatory clearance, the USD7.5bn cash payment and integration remain ahead, and TI ended Q3 with around USD13.65bn of debt after repaying USD500mn. Product migration, savings and deleveraging will determine whether the deal creates lasting value.


Key risks

AI funding is the main risk. October's chip sell-off reflected doubts over how hyperscalers will fund AI spending, and a capex slowdown would delay the 800V ramp, though management has yet to see one. China’s regulator could delay or condition the Silicon Labs deal, and its anti-dumping probe into US interface and gate-driver chips, where TI is the most exposed US supplier, remains unresolved.


Valuation: maintain BUY; TP raised to USD 391

Following stronger-than-expected margin conversion in Q3 and upward revisions to our Analog revenue forecasts, we raise our FY2028E EPS to USD12.62 from USD11.17 in our May initiation. We maintain our BUY call and raise our end-2028 target price to USD391 from USD346, implying approximately 27% upside from USD308.91.

TI has historically commanded a premium to its analog peers. Its current 12-month forward P/E of 27.4× compares with 25.8× for ADI, 18.1× for Infineon, 19.7× for STMicroelectronics and 14.2× for NXP. We believe this reflects TI's established analog franchise, extensive customer relationships and greater control over manufacturing costs and supply. While competitors also have access to 300mm manufacturing, TI differentiates itself through the scale of its internally owned 300mm analog production network.

Table 5: TI's P/E premium to analog peers

Company

Current forward P/E

5-year average

Texas Instruments

27.4×

26.3×

Analog Devices

25.8×

24.0×

Infineon

18.1×

17.7×

STMicroelectronics

19.7×

17.7×

NXP

14.2×

15.2×

Source: Bloomberg Finance L.P., iFAST Compilation. Data as of 27 October 2026.

We retain our 31x fair P/E. This premium is justified as the 300mm network lifts returns and AI and industrial content extends growth beyond the cycle. We forecast revenue growth of 18.5% in FY2027 and 16.0% in FY2028. EPS growth accelerates from 16.0% to 20.5% as Silicon Labs integration charges fall away and margins expand further.

Table 6: Valuation

FY25A

FY26E

FY27E

FY28E

Revenue (USD mn)

17,682

22,393

26,539

30,778

Revenue growth YoY

13.0%

26.6%

18.5%

16.0%

EPS (USD)

5.67

9.03

10.47

12.62

Earnings Growth YoY

11.4%

59.3%

16.0%

20.5%

Implied P/E

32.0x

34.2x

29.5x

24.5x

Current Price (USD)

308.91

Upside Potential (31x fair P/E)

26.7%

Target Price (USD)

391

Source: Bloomberg Finance L.P., iFAST Compilation. Data as of 27 October 2026.


Declaration:

For specific disclosure, at the time of publication of this report, IFPL (via its connected and associated entities) and the analyst who produced this report hold a NIL position in the abovementioned securities.

This research report was prepared with the assistance of artificial intelligence (AI) tools. iFAST Financial Pte Ltd does not rely exclusively on AI for content generation; the content of this report, including all investment theses, ratings, price targets and conclusions, has been independently reviewed and verified by the research analyst(s) to ensure accuracy and professional integrity.

All materials and contents found in this site are strictly for general circulation and informational purposes only and should not be considered as an offer, or solicitation, to deal in any of the funds or products found/identified in this site. While iFAST Financial Pte Ltd ("IFPL") has tried to provide accurate and timely information, there may be inadvertent delays, omissions, technical or factual inaccuracies and typographical errors. Any opinion or estimate contained in this report is made on a general basis and neither IFPL nor any of its servants or agents have given any consideration to nor have they or any of them made any investigation of the investment objective, financial situation or particular need of any user or reader, any specific person or group of persons. You should consider carefully if the products you are going to purchase are suitable for your investment objective, investment experience, risk tolerance and other personal circumstances. If you are uncertain about the suitability of the investment product, please seek advice from a financial adviser, before making a decision to purchase the investment product. Past performance is not indicative of future performance. The value of the investment products and the income from them may fall as well as rise. Opinions expressed herein are subject to change without notice. In respect of any matters arising from, or in connection with the said research analyses or research reports, recipients of the report are to contact IFPL at 10 Collyer Quay, #26-01 Ocean Financial Centre Building, Singapore 049315, or by telephone at +65 6557 2853. Where the report contains research analyses or research reports from a foreign research house and if the recipient of such research analyses or research reports is not an accredited investor, expert investor, institutional investor or an ex-accredited investor, IFPL accepts legal responsibility for the contents of such analyses or reports to such persons only to the extent as required by law. Please note that only certain security(ies) herein are available to all investors, while the rest are only available for certain persons to invest in, such as Accredited Investors (as defined in the Securities and Futures Act) or one who invests at least S$200,000 (or its equivalent currency) per transaction. To qualify as an Accredited Investor, one needs to submit a declaration form and certain relevant supporting documents, according to iFAST’s prevailing policies and procedures.

Please read our full disclaimers on the website at ( https://fsm.global/sg/policies/328125/investment-account-terms-&-conditions).

iFAST Financial Pte Ltd (IFPL) (registered address: 10 Collyer Quay #26-01 Ocean Financial Centre Singapore 049315, Telephone: 6557 2000) holds the Financial Advisers Licence issued by the Monetary Authority of Singapore ('MAS') to conduct regulated activities of advising on securities, marketing of collective investment schemes and arranging of any contract of insurance in respect of life policies, other than a contract of reinsurance and the Capital Markets Services Licence issued by the MAS to conduct regulated activities of dealing in securities and providing custodial services for securities. While IFPL has made every effort to ensure the independence of the report's contents, IFPL's nature of business is such that IFPL and its connected and associated entities together with their respective directors, officers and staff may be involved in providing dealing or investment-related services in the abovementioned securities, and have taken or may take positions in the securities mentioned in this report, and may also act as the principal for any buy or sell trades.